Amgen Inc.
| Name | Area | Department | Start Year | Stop Year | Advisor |
|---|---|---|---|---|---|
| Heather A. Arnett | Neuroinflammation, multiple sclerosis | ||||
| Francis X. Brennan | |||||
| Ming Chen | Regulatory Sciences; Pharmaceutical Outcomes and Policy | 2014 | 2014 | Min Wu (research assistant) | |
| Fuyi Chen | 2014 | 2018 | Jaime Grutzendler (post-doc) | ||
| David Immke | Neuroscience | ||||
| Matt Kelley | Epilepsy | ||||
| Samir Koirala | Alzheimer's Disease, Angelman Syndrome, Neurodevelopmental Disorders, Brain Development, Cerebellum, Polymicrogyria, Neuroinflammation, Schwann cells, Neuromuscular junction, Synapse Development, Nerve Regeneration, Peripheral Neuropathy, Neuropathic Pain | ||||
| John H Lawrence III | Biomechanics, Ankle Joint Torque | ||||
| April Le | Pain Nociception, blood-brain barrier | ||||
| Barton H. Manning | Pain | ||||
| Mark Sayles | Auditory system; electrophysiology; clinical development | ||||
| Ann H. Shim | Mechanisms of Drug Action, Molecular Neuroscience, Neurobiology of Disease, Signal Transduction | Murali Prakriya (post-doc) | |||
| James J. Treanor | |||||
| Andrew A. Welcher | Neurotrophins, tyrosine kinase receptors, myelin proteins, peripheral neuropathy |